⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Luis CorreaM.D.

Internal Medicine · West New York, NJ 7093

NPI: 1063771301

Share:

13

🟢 Low

Risk Flags

Opioid + benzodiazepine co-prescriberHigh fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

9,450

Total Claims

$1.3M

Drug Cost

498

Beneficiaries

$2,649

Cost/Patient

Risk Score Breakdown 13/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

-36%

Opioid rate vs peers

1.4% vs 2.2% avg

+88%

Cost per patient vs peers

$2,649 vs $1,411 avg

+46%

Brand preference vs peers

15.5% vs 10.6% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

1.4%

Opioid Rate

135

Opioid Claims

$886

Opioid Cost

Long-Acting Rate

Brand vs Generic

85% generic

Brand: 1,445 claims · $1.1M

Generic: 7,879 claims · $213K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Semaglutide139$169K
Empagliflozin92$128K
Sitagliptin Phosphate63$64K
Sitagliptin Phos/Metformin Hcl60$54K
Semaglutide30$53K
Linagliptin46$49K
Dulaglutide19$39K
Insulin Glargine,hum.Rec.Anlog50$38K
Linaclotide53$38K
Dapagliflozin Propanediol33$31K
Plecanatide30$24K
Ubrogepant13$24K
Apixaban20$21K
Rimegepant Sulfate12$20K
Icosapent Ethyl25$18K

Prescribing Profile

133

Unique Drugs

$244K

IRA Negotiated Drugs

$261K

GLP-1 Drugs

13.0

Anomaly Score

Patient Profile

71

Avg Age

63%

Female

1.32

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data